Biochemistry, Genetics and Molecular Biology
COL4A5
100%
Exon
80%
Genetics
76%
Molecular Genetics
72%
Dysplasia
58%
Allele
48%
Missense Mutation
44%
Genotype Phenotype Correlation
40%
Klinefelter Syndrome
38%
X Chromosome
33%
X-Inactivation
33%
Autosomal Dominant Inheritance
32%
Type IV Collagen
31%
Cytogenetics
31%
Genotyping
31%
Proband
31%
Exome Sequencing
30%
Multiplex Ligation-Dependent Probe Amplification
29%
Mosaicism
28%
Fibroblast
28%
Nonsense Mutation
27%
Autosomal Recessive Inheritance
25%
Nondisjunction
23%
First Trimester Pregnancy
23%
Genetic Background
23%
Ring Chromosome
23%
Haplotype
22%
Genomics
21%
Missense
20%
Karyotype
19%
COL4A4
19%
Intron
19%
Codon
18%
Metaphase
18%
Chorion Villus
18%
Gene Mutation
18%
Trisomy
16%
Chromosome 21
16%
Next Generation Sequencing
15%
Prevalence
15%
Cathepsin K
15%
Nomenclature
15%
Chromosome 13
15%
Gene Linkage
15%
Angelman Syndrome
15%
Amino Acids
15%
DNA Sequence
14%
Phosphotransferase
12%
Kinase
12%
Arginine
12%
Medicine and Dentistry
Alport Syndrome
33%
Disease
27%
Ectodermal Dysplasia
19%
Arm
19%
Genetic Screening
16%
Dysplasia
15%
Hypohidrotic Ectodermal Dysplasia
15%
Genetic Background
15%
Genotype Phenotype Correlation
15%
Genetic Disorder
13%
Collagen Type 4
12%
X Chromosome Inactivation
11%
Renal Failure
11%
Allele
11%
Hip Dysplasia
10%
Exome Sequencing
10%
Multiplex Ligation Dependent Probe Amplification
10%
Hearing Impairment
10%
Chromosome Analysis
10%
Hyperhidrosis
10%
Cross Sectional Study
10%
Mosaicism
10%
Exon
9%
Family History
9%
P21
9%
Diagnosis
9%
Hematuria
9%
Palmoplantar Keratoderma
9%
Proteinuria
9%
Griscelli Syndrome
7%
Melanosome
7%
Tooth Development
7%
Missense Mutation
7%
Nondisjunction
7%
Chromosome 13
7%
Retrospective Study
7%
Parathyroid Hormone
7%
Nonepidermolytic Palmoplantar Keratoderma
7%
Corynebacterium Infection
7%
Amelogenesis Imperfecta
7%
Face Malformation
7%
Hip
7%
Cataplexy
7%
Angelman Syndrome
7%
Polycystic Kidney Disease
7%
Clinical Finding
7%
Chorionic Villus Sampling
7%
Complementary DNA
7%
Karyotype
7%
Chondrodysplasia
7%
